Header menu link for other important links
X
Antifungal activity of Streptomyces VITSVK5 spp. against drug resistant Aspergillus clinical isolates from pulmonary tuberculosis patients
Kumar S,
Published in Elsevier BV
2010
Volume: 20
   
Issue: 2
Pages: 101 - 107
Abstract
Objective: Research of isolates producing antifungal activity. Material and methods: An actinomycetes strain having anti-Aspergillus activity against multidrug drug resistant clinical isolates was isolated from marine sediment samples collected at Marakkanam coast of Bay of Bengal, India. The strain was characterized by polyphasic taxonomic approach and identified as a member of the genus . Streptomyces. Based on the phenotypic and phylogenetic analysis, the strain was classified as a new species of the genus . Streptomyces and designated as . Streptomyces VITSVK5 spp. The G. +. C content of the isolated DNA is 71.3 mol% and the 16S rDNA sequence of the strain showed 93% similarity with . Streptomyces MSU2261. The media and growth conditions were optimized for maximal growth under shake flask conditions by measuring the dry weight of mycelium. Eleven multidrug resistant (MDR) . Aspergillus strains were isolated from sputum samples collected voluntarily from the pulmonary tuberculosis patients. Results: The isolated MDR strains showed the MIC value between 4-16μg/ml against the tested antifungal drugs, amphotericin B, itraconazole, ketoconazole and fluconazole. Ethyl acetate crude extract of . Streptomyces VITSVK5 spp. exhibited significant antifungal activity against MDR strains with the zone of inhibition ranging from 22 to 28. mm and the MIC value of 0.125-4μg/ml. Conclusion: The isolated . Streptomyces is a good candidate for the extraction and the purification of its antifungal metabolite. © 2010 Elsevier Masson SAS.
About the journal
JournalData powered by TypesetJournal de Mycologie Médicale
PublisherData powered by TypesetElsevier BV
ISSN1156-5233
Open Access0